ZEFIT is a biopharmaceutical company that uses advanced zebrafish models for drug discovery and development. They use innovative diagnostic technologies and artificial intelligence to accelerate preclinical research, particularly in neurological disorders, bridging the gap between early-stage research and clinical application. Zebrafish models are being utilized in preclinical research to expedite and ensure the precise identification of potential therapeutics.
Advertisements
Advantages of the zebrafish models:
- Zebrafish offer significant advantages in disease treatment strategies due to their conserved genes, which are crucial for maintaining fundamental biological functions across organisms, making them a promising model for studying human diseases and drug discovery.
- The zebrafish model enhances disease research by efficiently identifying disease targets, providing proof-of-concept data for therapeutic strategies, and overcoming research bottlenecks in drug development by studying individual and organ levels.
- Major pharmaceutical companies like Novartis and Pfizer have reported cost reductions of over 10 million annually using zebrafish data in drug research. The FDA has accepted zebrafish-based data for Investigational New Drug applications in 2019, 2020, and 2021, highlighting its growing importance in regulatory approval processes. Zebrafish offers an efficient and ethical alternative to traditional animal models.
- Zebrafish model utilization has improved owing to advancements in drug delivery methods, including oral administration and intravenous injection. These enabled more precise drug absorption and precision in preclinical studies, making it an effective model for pharmaceutical research.
If you are looking for a zebrafish drug development, you can find them at ZEFIT.
Click here if you have any inquires in ZEFIT services.
View more: Advanced Zebrafish Models for Drug Discovery
